BIO-ESTHETIC INDIRECT ABUTMENT

K970073 · Steri-Oss, Inc. · NHA · Jul 3, 1997 · Dental

Device Facts

Record IDK970073
Device NameBIO-ESTHETIC INDIRECT ABUTMENT
ApplicantSteri-Oss, Inc.
Product CodeNHA · Dental
Decision DateJul 3, 1997
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3630
Device ClassClass 2

Intended Use

The intended use of Steri-Oss’ Bio-Esthetic Indirect Abutment, an abutment retained with a lingual retaining screw, is to provide a stable, secure foundation upon which a prosthetic appliance (the purpose of which is restoration of masticatory function in the edentulous or partially edentulous patient) can be attached, yet remain retrievable.

Device Story

Bio-Esthetic Indirect Abutment serves as interface between endosseous dental implant (root) and prosthetic appliance (crown). Device consists of abutment and lingual retaining screw; enables secure attachment of prosthesis to implant while maintaining retrievability. Used by dental professionals in clinical settings to restore chewing function. Abutment features oval cylinder design, available in straight or 15-degree angulated configurations. Titanium alloy construction ensures biocompatibility and structural support. Device is provided sterile.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Materials: Titanium alloy (abutment/screw), Gold alloy (retaining screw). Design: Oval cylinder, straight or 15-degree angulation. Dimensions: 0.350-0.359 in. height, 0.230-0.283 in. diameter. Sterilization: Provided sterile.

Indications for Use

Indicated for edentulous or partially edentulous patients requiring restoration of masticatory function via prosthetic appliances supported by endosseous dental implants.

Regulatory Classification

Identification

An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} Original 510(k) Bio-Esthetic Indirect Abutment K970073 Section 6 510(k) Summary JUL - 3 1997 # letterhead ## 510(k) Summary ### Manufacturer Information: Submitter's Name: Steri-Oss Inc. Address: 22895 Eastpark Drive Yorba Linda, CA 92887, U.S.A. Contact's Name: Jeff Hausheer, Ph.D. Regulatory Affairs Specialist Phone: 714-282-4800, extension 3815 Date Prepared: January 1997 ### Device Names: Common Name: Endosseous Dental Implant Abutment and Lingual Retaining Screw Trade Name: Bio-Esthetic Indirect Abutment Classification Name: Endosseous implant ### Predicate Device: Substantial equivalence is claimed to Friatec's "Frialit-2 MH-6 Abutment". ### Device Description: **How device functions:** The Steri-Oss Lingual Bio-Esthetic Indirect Abutment is designed to be used in conjunction with endosseous implants as part of a system to provide support for prosthetic appliances to restore patient chewing function, and includes utilization of a lingual retaining screw for abutment retention which allows retrievability. Page 1 of 3 Steri-Oss Inc. - January 1997 41 {1} Original 510(k) Bio-Esthetic Indirect Abutment # Section 6 ## 510(k) Summary (continued) ### letterhead **510(k) Summary (continued)** ### Device Description (continued): **Scientific concepts:** Natural dentition is composed of a root (subgingival) and a crown (supragingival). Implant system designs in existence are intended to mimic this structure to aid the patient in restoring natural masticatory function. The implant is designed to serve as the root of the artificial tooth and the abutment/prosthetic is designed to serve as the crown. The abutment must be securely fastened to the implant. A lingual retaining screw may be used for this purpose, while retaining retrievability. **Characteristics:** The Bio-Esthetic Indirect Abutment is a conventional abutment designed for use with a lingual screw which, when tightened, retains the abutment in place. ### Intended Use: The intended use of Steri-Oss’ Bio-Esthetic Indirect Abutment, an abutment retained with a lingual retaining screw, is to provide a stable, secure foundation upon which a prosthetic appliance (the purpose of which is restoration of masticatory function in the edentulous or partially edentulous patient) can be attached, yet remain retrievable. ### Comparison to Predicate: Table 6.1 provides a comparison of the technological characteristic of the Steri-Oss implant to the predicate. Page 2 of 3 Steri-Oss Inc. - January 1997 {2} Original 510(k) Bio-Esthetic Indirect Abutment # Section 6 ## 510(k) Summary (continued) ### Table 6.1 #### Product Comparison - Abutment with Lingual Retaining Screw | Characteristic | PREDICATE Friatec's “Frialit MH-6 Abutment” | NEW DEVICE Steri-Oss' Bio-Esthetic Indirect Abutment | | --- | --- | --- | | Abutment and Screw Material | Titanium alloy | Same | | Retaining Screw Cellar Material | Gold alloy | Gold alloy | | Abutment Design | Cylindrical shape | Oval cylinder shape with and without angulation | | Height (mm) | 0.130 in. to 0.256 in. | 0.350 in. to 0.0359 in. | | Maximum Diameter (mm) | 0.067 in. to 0.110 in. | 0.230 in. to 0.283 in. | | Abutment Angulation | Straight | Straight and 15° | | Packaging | Unknown | Chevron pouch in plastic case | | Sterility | Unknown | Provided Sterile | ### Performance Data: Not applicable. Page 3 of 3 Steri-Oss Inc. - January 1997 {3} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room –WO66-G609 Silver Spring, MD 20993-0002 SEP 17 2010 Ms. Phuong Nguyen Son Regulatory Affairs Manager Nobel Biocare USA, LLC 22715 Savi Ranch Parkway Yorba Linda, California 92887 Re: K970073 Trade/Device Name: Bio-Esthetic Indirect Abutment Regulation Number: 21 CFR 872.3630 Regulation Name: Bio-Esthetic Indirect Abutment Regulatory Class: II Product Code: NHA Dated: July 28, 2010 Received: July 29, 2010 Dear Ms. Nguyen Son: This letter corrects our substantially equivalent letter of July 28, 2010. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4} Page 2- Ms. Nguyen Son Please be advised that FDA’s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health’s (CDRH’s) Office of Compliance. Also, please note the regulation entitled, “Misbranding by reference to premarket notification” (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH’s Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, ![img-0.jpeg](img-0.jpeg) Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control Office of Device Evaluation Center for Devices and Radiological Health {5} Original 510(k) Bio-Esthetic Indirect Abutment Section 9 Indications for Use Page 1 of 1 510(k) Number (if known): K970073 Device Name: Bio-Esthetic Indirect Abutment Indications For Use: The intended use of Steri-Oss' Bio-Esthetic Indirect Abutment, an abutment retained with a lingual retaining screw, is to provide a stable, secure foundation upon which a prosthetic appliance (the purpose of which is restoration of masticatory function in the edentulous and partially edentulous patient) can be attached, yet remain retrievable. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) (Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devices 510(k) Number K970073 Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use ☑ OR Over-The-Counter Use ☐ (Per 21 CFR 801.109) (Optional Format 1-2-96) Steri-Oss inc. - January 1997
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%